304 related articles for article (PubMed ID: 18434768)
1. Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects.
Shehata BM; Stockwell CA; Castellano-Sanchez AA; Setzer S; Schmotzer CL; Robinson H
Adv Anat Pathol; 2008 May; 15(3):165-71. PubMed ID: 18434768
[TBL] [Abstract][Full Text] [Related]
2. Second hit deletion size in von Hippel-Lindau disease.
Gläsker S; Sohn TS; Okamoto H; Li J; Lonser RR; Oldfield EH; Vortmeyer AO; Zhuang Z
Ann Neurol; 2006 Jan; 59(1):105-10. PubMed ID: 16261628
[TBL] [Abstract][Full Text] [Related]
3. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
4. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.
Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ
Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701
[TBL] [Abstract][Full Text] [Related]
5. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
6. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
7. Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome.
Santarpia L; Lapa D; Benvenga S
Ann N Y Acad Sci; 2006 Aug; 1073():198-202. PubMed ID: 17102087
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations in the von Hippel-Lindau gene in Italian patients.
Ciotti P; Garuti A; Gulli R; Ballestrero A; Bellone E; Mandich P
Eur J Med Genet; 2009; 52(5):311-4. PubMed ID: 19464396
[TBL] [Abstract][Full Text] [Related]
10. Von Hippel-Lindau disease and endocrine tumour susceptibility.
Woodward ER; Maher ER
Endocr Relat Cancer; 2006 Jun; 13(2):415-25. PubMed ID: 16728571
[TBL] [Abstract][Full Text] [Related]
11. von Hippel-Lindau disease: a clinical and scientific review.
Maher ER; Neumann HP; Richard S
Eur J Hum Genet; 2011 Jun; 19(6):617-23. PubMed ID: 21386872
[TBL] [Abstract][Full Text] [Related]
12. A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease.
Jia D; Tang B; Shi Y; Wang J; Sun Z; Chen Z; Zhang L; Xia K; Jiang H
J Clin Neurosci; 2013 Jun; 20(6):842-7. PubMed ID: 23632291
[TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau disease.
Maher ER
Curr Mol Med; 2004 Dec; 4(8):833-42. PubMed ID: 15579030
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations in the new E1' cryptic exon of the
Buffet A; Calsina B; Flores S; Giraud S; Lenglet M; Romanet P; Deflorenne E; Aller J; Bourdeau I; Bressac-de Paillerets B; Calatayud M; Dehais C; De Mones Del Pujol E; Elenkova A; Herman P; Kamenický P; Lejeune S; Sadoul JL; Barlier A; Richard S; Favier J; Burnichon N; Gardie B; Dahia PL; Robledo M; Gimenez-Roqueplo AP
J Med Genet; 2020 Nov; 57(11):752-759. PubMed ID: 31996412
[TBL] [Abstract][Full Text] [Related]
15. Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations.
Schuster J; Fatima A; Schwarz F; Klar J; Laan L; Dahl N
Stem Cell Res; 2019 Jul; 38():101474. PubMed ID: 31176917
[TBL] [Abstract][Full Text] [Related]
16. Novel gene mutation in von Hippel-Lindau disease - a report of two cases.
Wang J; Cao W; Wang Z; Zhu H
BMC Med Genet; 2019 Dec; 20(1):194. PubMed ID: 31823746
[TBL] [Abstract][Full Text] [Related]
17. Mosaicism in von Hippel-Lindau disease with severe renal manifestations.
Wu P; Zhang N; Wang X; Li T; Ning X; Bu D; Gong K
Clin Genet; 2013 Dec; 84(6):581-4. PubMed ID: 23384228
[TBL] [Abstract][Full Text] [Related]
18. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
[TBL] [Abstract][Full Text] [Related]
19. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
[TBL] [Abstract][Full Text] [Related]
20. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
